- Published on
Toxicology – Elapid Snake Envenomation
Source
Elapid snakes are found primarily in tropical and subtropical regions worldwide. They possess fixed, hollow fangs used to deliver venom. This group includes coral snakes, cobras, mambas, taipans, adders, and certain sea snakes.
Typical Presentation
A patient may present after a bite from a brightly colored or unfamiliar snake, initially with mild local symptoms but progressing to neurological changes. Early complaints may include tingling or numbness at the bite site.
Clinical Features
Local findings are often less severe than with pit viper bites and may include mild pain, paresthesia, and minimal swelling. Systemic effects are more prominent and include nausea, vomiting, altered mental status, difficulty swallowing, double vision, drooping eyelids (ptosis), muscle twitching, excessive salivation, jaw stiffness, hypotension, tachycardia, and potentially respiratory failure due to paralysis.
Mechanism of Action
Elapid venom is primarily neurotoxic. It interferes with neuromuscular transmission by blocking postsynaptic acetylcholine receptors, particularly at nicotinic receptors in skeletal muscle. This can lead to progressive paralysis, including involvement of the diaphragm and respiratory muscles.
Management
Treatment is mainly supportive, with close monitoring of airway and respiratory function. Early intubation and mechanical ventilation should be considered if there are signs of respiratory compromise. Consultation with poison control or toxicology specialists is essential to determine availability of appropriate antivenom (such as coral snake antivenin, where applicable).
Key Points
- Elapid bites often cause minimal local injury but significant systemic neurotoxicity.
- Respiratory failure is the most serious complication and requires prompt recognition.
- Some species require prolonged contact (e.g., coral snakes) to effectively deliver venom.
- Identification rules based on color patterns apply only in specific geographic regions and should be used cautiously.
- Published on
Toxicology – Drug “Stuffers” and “Packers”
Overview
“Stuffers” and “packers” refer to individuals who conceal illicit drugs within their bodies, typically to evade law enforcement. These two groups differ significantly in the quantity of drugs involved, the method of concealment, and the associated risks.
Stuffers
Definition
Stuffers are individuals who rapidly swallow small amounts of drugs—commonly cocaine, crack, or heroin—when attempting to avoid detection. The packaging is often poorly secured, increasing the risk of leakage and absorption.
Detection
Diagnosis may rely on witness reports, patient disclosure, or clinical suspicion. Imaging studies such as plain abdominal X-rays may be used but are often unreliable in detecting small or poorly wrapped packets.
Toxicity
Symptoms can occur unpredictably depending on the substance and whether a packet ruptures. Sympathomimetic features (e.g., tachycardia, hypertension, agitation) are common with stimulant drugs, while other substances produce their respective toxidromes.
Management
Treatment often includes activated charcoal, particularly for substances like cocaine that bind well to it. Whole bowel irrigation (WBI) with polyethylene glycol solution may be considered depending on the situation.
Packers (“Body Packers”)
Definition
Packers, often referred to as “drug mules,” intentionally ingest large quantities of drugs—typically well-packaged—for transport across borders. The total amount can be substantial, often reaching hundreds of grams or more.
Detection
Imaging is more reliable in these cases. Plain abdominal X-rays may reveal multiple uniform radiopaque packets. If inconclusive, computed tomography (CT) with contrast is more sensitive.
Toxicity
If a packet ruptures, massive drug release can occur, often resulting in severe toxicity and a high risk of death, particularly with stimulants like cocaine.
Management
Patients with signs of obstruction or suspected packet rupture require urgent surgical evaluation. In stable, asymptomatic individuals, whole bowel irrigation is commonly used to facilitate passage of packets. Adjunctive medications such as antiemetics or prokinetics may be used. Activated charcoal may be considered selectively.
Key Points
Overview
“Stuffers” and “packers” refer to individuals who conceal illicit drugs within their bodies, typically to evade law enforcement. These two groups differ significantly in the quantity of drugs involved, the method of concealment, and the associated risks.
Stuffers
Definition
Stuffers are individuals who rapidly swallow small amounts of drugs—commonly cocaine, crack, or heroin—when attempting to avoid detection. The packaging is often poorly secured, increasing the risk of leakage and absorption.
Detection
Diagnosis may rely on witness reports, patient disclosure, or clinical suspicion. Imaging studies such as plain abdominal X-rays may be used but are often unreliable in detecting small or poorly wrapped packets.
Toxicity
Symptoms can occur unpredictably depending on the substance and whether a packet ruptures. Sympathomimetic features (e.g., tachycardia, hypertension, agitation) are common with stimulant drugs, while other substances produce their respective toxidromes.
Management
Treatment often includes activated charcoal, particularly for substances like cocaine that bind well to it. Whole bowel irrigation (WBI) with polyethylene glycol solution may be considered depending on the situation.
Packers (“Body Packers”)
Definition
Packers, often referred to as “drug mules,” intentionally ingest large quantities of drugs—typically well-packaged—for transport across borders. The total amount can be substantial, often reaching hundreds of grams or more.
Detection
Imaging is more reliable in these cases. Plain abdominal X-rays may reveal multiple uniform radiopaque packets. If inconclusive, computed tomography (CT) with contrast is more sensitive.
Toxicity
If a packet ruptures, massive drug release can occur, often resulting in severe toxicity and a high risk of death, particularly with stimulants like cocaine.
Management
Patients with signs of obstruction or suspected packet rupture require urgent surgical evaluation. In stable, asymptomatic individuals, whole bowel irrigation is commonly used to facilitate passage of packets. Adjunctive medications such as antiemetics or prokinetics may be used. Activated charcoal may be considered selectively.
Key Points
- Stuffers involve smaller amounts with higher risk of leakage due to poor packaging.
- Packers carry larger quantities with potentially fatal consequences if rupture occurs.
- Imaging plays a crucial role in diagnosis, especially in packers.
- Management ranges from supportive care to urgent surgical intervention depending on clinical status.
- Published on
Toxicology – Methylenedioxymethamphetamine (MDMA, “Ecstasy”)
Source
MDMA is a synthetic recreational drug commonly sold as colorful tablets or capsules, often branded with logos. Due to its illicit production, purity is highly variable, and tablets are frequently mixed with other substances such as amphetamines, dextromethorphan, synthetic cathinones, or opioids. It is also known as ecstasy, E, X, or XTC.
Typical Presentation
Users often present after recreational use in party or club settings, describing heightened sensory experiences and emotional changes. Physical findings may include increased heart rate, elevated blood pressure, and mild sweating.
Clinical Features
Effects typically begin within 30–45 minutes and last several hours. Stimulant effects include tachycardia, hypertension, increased energy, rapid breathing, and dilated pupils. Psychologically, users may experience enhanced empathy, emotional openness, and altered perception. Adverse effects include agitation, hyperthermia, hyponatremia, and risk of serotonin syndrome. After the drug wears off, users often report fatigue and low mood. Chronic use has been associated with depressive symptoms.
Mechanism of Action
MDMA increases the release of serotonin, norepinephrine, and dopamine from presynaptic neurons, leading to both stimulant and empathogenic effects.
Management
Treatment is supportive. Benzodiazepines are used to control agitation, anxiety, and autonomic symptoms such as tachycardia. Careful monitoring for complications such as hyperthermia and electrolyte disturbances is important.
Key Points
Source
MDMA is a synthetic recreational drug commonly sold as colorful tablets or capsules, often branded with logos. Due to its illicit production, purity is highly variable, and tablets are frequently mixed with other substances such as amphetamines, dextromethorphan, synthetic cathinones, or opioids. It is also known as ecstasy, E, X, or XTC.
Typical Presentation
Users often present after recreational use in party or club settings, describing heightened sensory experiences and emotional changes. Physical findings may include increased heart rate, elevated blood pressure, and mild sweating.
Clinical Features
Effects typically begin within 30–45 minutes and last several hours. Stimulant effects include tachycardia, hypertension, increased energy, rapid breathing, and dilated pupils. Psychologically, users may experience enhanced empathy, emotional openness, and altered perception. Adverse effects include agitation, hyperthermia, hyponatremia, and risk of serotonin syndrome. After the drug wears off, users often report fatigue and low mood. Chronic use has been associated with depressive symptoms.
Mechanism of Action
MDMA increases the release of serotonin, norepinephrine, and dopamine from presynaptic neurons, leading to both stimulant and empathogenic effects.
Management
Treatment is supportive. Benzodiazepines are used to control agitation, anxiety, and autonomic symptoms such as tachycardia. Careful monitoring for complications such as hyperthermia and electrolyte disturbances is important.
Key Points
- Effects are unpredictable due to frequent adulteration.
- Hyponatremia and hyperthermia are important complications to monitor.
- Combining MDMA with other psychoactive substances increases risk of toxicity.
- Products marketed as “Molly” may not contain pure MDMA and can include other synthetic compounds.
- Published on
Toxicology – Crotalid Snake Envenomation
Source
Crotalid snakes (pit vipers) are the most common cause of venomous snakebites in the United States. These include rattlesnakes, copperheads, and cottonmouths (water moccasins). They are characterized by heat-sensing pits located near their eyes.
Typical Presentation
A patient presents after a snakebite, often involving provocation of the animal. Two puncture wounds (“fang marks”) are typically visible, followed by rapid onset of pain and swelling at the affected site.
Clinical Features
Initial symptoms include severe burning pain at the bite site, followed by redness, warmth, swelling, bruising, and blister formation. Edema may spread along the affected limb and can lead to compartment syndrome. Systemic manifestations may include nausea, vomiting, altered taste, tingling sensations, hypotension, coagulopathy (including disseminated intravascular coagulation), and cardiovascular collapse in severe cases.
Severity Classification
Mechanism of Action
Crotalid venom contains a mixture of cytotoxic, hemotoxic, and neurotoxic components that damage tissue, disrupt coagulation pathways, and may affect neuromuscular function.
Management
Initial evaluation includes laboratory studies such as complete blood count, coagulation profile (PT/PTT), fibrin levels, D-dimer, and creatine phosphokinase (CPK). Serial assessment of limb swelling is essential. Some bites may be “dry” (no venom injected) and require only supportive care.
For progressive local swelling or systemic toxicity, antivenom (CroFab) is indicated, typically starting with 4–6 vials. Patients require close monitoring, as repeat dosing may be necessary depending on clinical response.
Key Points
Source
Crotalid snakes (pit vipers) are the most common cause of venomous snakebites in the United States. These include rattlesnakes, copperheads, and cottonmouths (water moccasins). They are characterized by heat-sensing pits located near their eyes.
Typical Presentation
A patient presents after a snakebite, often involving provocation of the animal. Two puncture wounds (“fang marks”) are typically visible, followed by rapid onset of pain and swelling at the affected site.
Clinical Features
Initial symptoms include severe burning pain at the bite site, followed by redness, warmth, swelling, bruising, and blister formation. Edema may spread along the affected limb and can lead to compartment syndrome. Systemic manifestations may include nausea, vomiting, altered taste, tingling sensations, hypotension, coagulopathy (including disseminated intravascular coagulation), and cardiovascular collapse in severe cases.
Severity Classification
- Mild envenomation: Local pain and swelling without coagulation abnormalities
- Moderate envenomation: Local effects with evidence of coagulation disturbances
- Severe envenomation: Systemic toxicity such as shock, pulmonary edema, coagulopathy, and cardiovascular instability
Mechanism of Action
Crotalid venom contains a mixture of cytotoxic, hemotoxic, and neurotoxic components that damage tissue, disrupt coagulation pathways, and may affect neuromuscular function.
Management
Initial evaluation includes laboratory studies such as complete blood count, coagulation profile (PT/PTT), fibrin levels, D-dimer, and creatine phosphokinase (CPK). Serial assessment of limb swelling is essential. Some bites may be “dry” (no venom injected) and require only supportive care.
For progressive local swelling or systemic toxicity, antivenom (CroFab) is indicated, typically starting with 4–6 vials. Patients require close monitoring, as repeat dosing may be necessary depending on clinical response.
Key Points
- Not all snakebites result in envenomation; some are dry bites.
- Antivenom is the mainstay of treatment for significant envenomation.
- Surgical intervention such as fasciotomy is rarely required.
- Envenomation can evolve over time, so close observation is essential.
- Published on
Toxicology – Nitrous Oxide
Source
Nitrous oxide is a dissociative anesthetic available from medical gas supplies, automotive sources, and small canisters (“chargers”) used in whipped cream dispensers. It is often inhaled directly from these sources or via balloons at social events.
Typical Presentation
A college student presents with numbness and tingling in the hands and feet along with difficulty walking. On further questioning, he admits to frequent recreational use of nitrous oxide at parties, often inhaling it from balloons over several months.
Clinical Features
Acute effects include euphoria, analgesia, depersonalization, derealization, impaired coordination, reduced anxiety, and altered auditory perception. With chronic use, vitamin B12 deficiency may develop, leading to neurological symptoms such as paresthesia, ataxia, and hematologic abnormalities including megaloblastic anemia.
Mechanism of Action
Nitrous oxide acts as a weak dissociative anesthetic, likely through NMDA receptor antagonism and GABA receptor activation.
Management
Treatment involves discontinuation of exposure and supportive care. Vitamin B12 supplementation is indicated in patients with deficiency and neurological complications.
Key Points
Source
Nitrous oxide is a dissociative anesthetic available from medical gas supplies, automotive sources, and small canisters (“chargers”) used in whipped cream dispensers. It is often inhaled directly from these sources or via balloons at social events.
Typical Presentation
A college student presents with numbness and tingling in the hands and feet along with difficulty walking. On further questioning, he admits to frequent recreational use of nitrous oxide at parties, often inhaling it from balloons over several months.
Clinical Features
Acute effects include euphoria, analgesia, depersonalization, derealization, impaired coordination, reduced anxiety, and altered auditory perception. With chronic use, vitamin B12 deficiency may develop, leading to neurological symptoms such as paresthesia, ataxia, and hematologic abnormalities including megaloblastic anemia.
Mechanism of Action
Nitrous oxide acts as a weak dissociative anesthetic, likely through NMDA receptor antagonism and GABA receptor activation.
Management
Treatment involves discontinuation of exposure and supportive care. Vitamin B12 supplementation is indicated in patients with deficiency and neurological complications.
Key Points
- Recreational use often involves specialized devices (“crackers”) to release gas from small canisters.
- Nitrous oxide is widely accessible and commonly misused in social settings.
- Chronic exposure can lead to significant neurological and hematologic complications due to vitamin B12 depletion.
- Published on
Toxicology – Common Rat Poisons and How They Work
Bromethalin
Bromethalin disrupts energy production by uncoupling oxidative phosphorylation within mitochondria, leading to cellular failure.
Strychnine
This toxin blocks glycine receptors in the central nervous system, resulting in severe, painful tonic–clonic seizures while the patient remains conscious.
Arsenic
Arsenic interferes with cellular energy production by inhibiting pyruvate dehydrogenase, ultimately reducing ATP generation.
Phosphides
Phosphide compounds release phosphine gas upon contact with moisture, a highly toxic substance that disrupts cellular respiration.
Thallium
Thallium interferes with potassium-dependent processes, impairing mitochondrial function and disrupting muscle and nerve activity.
Barium
Barium blocks potassium channels, leading to significant electrolyte disturbances and neuromuscular dysfunction.
Coumarin-Like Anticoagulants
These rodenticides act as vitamin K antagonists, impairing clotting factor synthesis and increasing bleeding risk.
Indanediones
A class of anticoagulant rodenticides (e.g., diphacinone, chlorophacinone, pindone) that interfere with coagulation pathways.
Tetramine
Tetramine is a potent, irreversible GABA antagonist that leads to severe, refractory seizures.
Phosphorus
Phosphorus is a highly toxic substance that causes direct cellular injury and organ damage.
Norbormide
Norbormide acts as a vasoconstrictor and calcium channel blocker, disrupting blood flow and cellular function.
Red Squill
Derived from a Mediterranean plant, red squill has cardiotoxic effects and has historically been used as a rodenticide.
ANTU (Alpha-Naphthylthiourea)
This compound causes pulmonary edema, particularly in rodents, leading to respiratory failure.
Bromethalin
Bromethalin disrupts energy production by uncoupling oxidative phosphorylation within mitochondria, leading to cellular failure.
Strychnine
This toxin blocks glycine receptors in the central nervous system, resulting in severe, painful tonic–clonic seizures while the patient remains conscious.
Arsenic
Arsenic interferes with cellular energy production by inhibiting pyruvate dehydrogenase, ultimately reducing ATP generation.
Phosphides
Phosphide compounds release phosphine gas upon contact with moisture, a highly toxic substance that disrupts cellular respiration.
Thallium
Thallium interferes with potassium-dependent processes, impairing mitochondrial function and disrupting muscle and nerve activity.
Barium
Barium blocks potassium channels, leading to significant electrolyte disturbances and neuromuscular dysfunction.
Coumarin-Like Anticoagulants
These rodenticides act as vitamin K antagonists, impairing clotting factor synthesis and increasing bleeding risk.
Indanediones
A class of anticoagulant rodenticides (e.g., diphacinone, chlorophacinone, pindone) that interfere with coagulation pathways.
Tetramine
Tetramine is a potent, irreversible GABA antagonist that leads to severe, refractory seizures.
Phosphorus
Phosphorus is a highly toxic substance that causes direct cellular injury and organ damage.
Norbormide
Norbormide acts as a vasoconstrictor and calcium channel blocker, disrupting blood flow and cellular function.
Red Squill
Derived from a Mediterranean plant, red squill has cardiotoxic effects and has historically been used as a rodenticide.
ANTU (Alpha-Naphthylthiourea)
This compound causes pulmonary edema, particularly in rodents, leading to respiratory failure.
- Published on
Toxicology – Understanding Warfarin Drug Interactions
Overview
Warfarin is a commonly prescribed anticoagulant used to prevent blood clots such as thrombosis and thromboembolism. It is effective, affordable, and well studied. However, it requires regular monitoring through the INR and may not be suitable for patients with poor compliance or high fall risk.
Mechanism of Action
Warfarin works by blocking vitamin K epoxide reductase, an enzyme needed to activate vitamin K. This reduces the activity of vitamin K–dependent clotting factors II, VII, IX, and X, thereby decreasing blood coagulation.
How Drug Interactions Occur
Warfarin interacts with other medications through several mechanisms. Some antibiotics reduce vitamin K–producing gut flora, increasing bleeding risk. Certain drugs displace warfarin from plasma proteins, raising its active levels. Others either increase or decrease its metabolism, altering its effect. Additionally, drugs like aspirin and NSAIDs independently increase bleeding risk.
High-Risk Drug Interactions
Amiodarone
Can significantly enhance warfarin’s effect, with interactions that may persist even after discontinuation.
Aspirin
Low doses may be acceptable, but higher doses for pain or inflammation increase bleeding risk and should be avoided.
Azole Antifungals
These medications inhibit warfarin metabolism, leading to increased anticoagulant effects.
Ciprofloxacin
May interact unpredictably, occasionally increasing bleeding risk.
Macrolide Antibiotics
Azithromycin is preferred over erythromycin and clarithromycin due to a lower risk of interaction.
Metronidazole
Significantly increases INR; coadministration should be avoided or require dose reduction of warfarin.
NSAIDs
These drugs impair platelet function and substantially increase the risk of bleeding.
Omeprazole
May increase INR and prolong bleeding time.
Phenytoin
Can either increase or decrease warfarin’s anticoagulant effect, making monitoring essential.
Statins
May elevate INR, especially after dose changes, requiring closer monitoring.
Trimethoprim-Sulfamethoxazole (TMP/SMX)
This combination has highly unpredictable effects and should generally be avoided.
Key Points
Overview
Warfarin is a commonly prescribed anticoagulant used to prevent blood clots such as thrombosis and thromboembolism. It is effective, affordable, and well studied. However, it requires regular monitoring through the INR and may not be suitable for patients with poor compliance or high fall risk.
Mechanism of Action
Warfarin works by blocking vitamin K epoxide reductase, an enzyme needed to activate vitamin K. This reduces the activity of vitamin K–dependent clotting factors II, VII, IX, and X, thereby decreasing blood coagulation.
How Drug Interactions Occur
Warfarin interacts with other medications through several mechanisms. Some antibiotics reduce vitamin K–producing gut flora, increasing bleeding risk. Certain drugs displace warfarin from plasma proteins, raising its active levels. Others either increase or decrease its metabolism, altering its effect. Additionally, drugs like aspirin and NSAIDs independently increase bleeding risk.
High-Risk Drug Interactions
Amiodarone
Can significantly enhance warfarin’s effect, with interactions that may persist even after discontinuation.
Aspirin
Low doses may be acceptable, but higher doses for pain or inflammation increase bleeding risk and should be avoided.
Azole Antifungals
These medications inhibit warfarin metabolism, leading to increased anticoagulant effects.
Ciprofloxacin
May interact unpredictably, occasionally increasing bleeding risk.
Macrolide Antibiotics
Azithromycin is preferred over erythromycin and clarithromycin due to a lower risk of interaction.
Metronidazole
Significantly increases INR; coadministration should be avoided or require dose reduction of warfarin.
NSAIDs
These drugs impair platelet function and substantially increase the risk of bleeding.
Omeprazole
May increase INR and prolong bleeding time.
Phenytoin
Can either increase or decrease warfarin’s anticoagulant effect, making monitoring essential.
Statins
May elevate INR, especially after dose changes, requiring closer monitoring.
Trimethoprim-Sulfamethoxazole (TMP/SMX)
This combination has highly unpredictable effects and should generally be avoided.
Key Points
- Warfarin has interactions with hundreds of medications.
- Although many antibiotics interact with warfarin, penicillin is considered relatively safer.
- Published on
Toxicology – Sedative–Hypnotic (Hypnosedative) Toxidrome
Sources
This toxidrome is associated with a broad group of central nervous system depressants, including alcohols, anticonvulsants, barbiturates, benzodiazepines, chloral hydrate, gamma-hydroxybutyrate (GHB), phenobarbital, meprobamate, methaqualone, muscle relaxants, tranquilizers, and sedative-hypnotic agents such as zolpidem.
Typical Presentation
Patients often present with decreased level of consciousness, ranging from drowsiness to coma. A common scenario involves combined use of substances (e.g., benzodiazepines with alcohol), leading to enhanced sedative effects. Individuals may appear intoxicated, with slurred speech, poor coordination, and impaired balance.
Clinical Features
Findings resemble alcohol intoxication and include respiratory depression, bradycardia, hypotension, ataxia, slurred speech, lethargy, disinhibition, decreased muscle tone, nystagmus, and progressive central nervous system depression. Severe cases may progress to stupor or coma. Effects are typically dose-dependent and often worsened by coingestion with alcohol. Certain agents such as GHB and methaqualone may lower the seizure threshold, while abrupt withdrawal from chronic use can lead to seizures and may be life-threatening.
Mechanism of Action
Most sedative–hypnotic agents exert their effects by enhancing gamma-aminobutyric acid (GABA) activity in the central nervous system, resulting in generalized neuronal inhibition.
Management
Treatment is primarily supportive, with attention to airway protection and hemodynamic stability. In patients with altered mental status, cervical spine precautions and neuroimaging may be necessary to exclude other causes. Endotracheal intubation should be considered in cases of compromised airway or respiratory depression. Flumazenil may be used cautiously in benzodiazepine-naïve patients, but it is generally avoided in chronic users due to the risk of precipitating severe withdrawal and seizures.
Key Points
- Alkalinization of urine can enhance elimination of certain barbiturates.
- Meprobamate toxicity may be managed with dialysis in severe cases.
- Published on
Toxicology – Opioid (Opiate) Toxidrome
Sources
Opioid toxicity can result from a wide range of substances, including natural and synthetic narcotics such as morphine, heroin, codeine, oxycodone, hydrocodone, fentanyl, methadone, hydromorphone, buprenorphine, oxymorphone, meperidine, propoxyphene, opium, and kratom. These agents may be taken orally, inhaled, or injected. Many prescription formulations combine opioids with acetaminophen, and fentanyl is also available as a transdermal patch.
Typical Presentation
Patients often present with decreased level of consciousness and respiratory depression. A classic presentation includes somnolence, slow breathing, pinpoint pupils, and evidence of intravenous drug use such as track marks. Administration of naloxone can rapidly reverse symptoms, leading to abrupt awakening.
Clinical Features
Common findings include central nervous system depression, bradypnea, bradycardia, reduced bowel sounds, and miosis. Peripheral vasodilation may result in hypotension and hypothermia. Severe toxicity can lead to respiratory arrest and coma. Complications may include noncardiogenic pulmonary edema and, in certain cases such as methadone use, QT prolongation. Repeated dosing of meperidine may provoke seizures.
Mechanism of Action
Opioids exert their effects by binding to specific opioid receptors in the central nervous system and gastrointestinal tract, leading to decreased neuronal excitability and slowed physiological functions.
Management
Treatment is primarily supportive, with airway and breathing support as needed. Naloxone is the antidote and should be administered in small, titrated doses (0.4–2 mg in adults, 0.1 mg/kg in children) every 1–2 minutes until adequate ventilation is restored. Care should be taken to avoid precipitating acute withdrawal. For long-acting opioids, a continuous naloxone infusion (approximately two-thirds of the effective reversal dose per hour) may be required. Whole bowel irrigation may be considered in cases of ingestion of sustained-release formulations or transdermal patches.
Key Points
- Naloxone has a shorter duration of action than many opioids, so repeated dosing or infusion may be necessary.
- Prolonged unconsciousness can lead to complications such as rhabdomyolysis.
- Some opioids, such as propoxyphene, may cause cardiac conduction abnormalities and seizures.
- Many opioid combination products contain acetaminophen, increasing the risk of combined toxicity.
- Transdermal systems and “abuse-deterrent” formulations may still be misused through extraction methods.
- Published on
Toxicology – Sympathomimetic Toxidrome
Sources
Sympathomimetic agents are substances that stimulate the sympathetic nervous system by increasing catecholamine activity. They may act directly on receptors (e.g., alpha- or beta-agonists) or indirectly by increasing catecholamine release, blocking reuptake, or inhibiting breakdown. Common examples include cocaine, amphetamines, MDMA, ephedrine, pseudoephedrine, epinephrine, MAO inhibitors, and synthetic stimulants such as “bath salts” (e.g., mephedrone).
Typical Presentation
Patients typically present in an agitated, hyperactive state. A common scenario involves stimulant use followed by symptoms such as chest pain, anxiety, and marked vital sign abnormalities including hypertension, tachycardia, and hyperthermia.
Clinical Features
This toxidrome reflects a “fight-or-flight” response. Key findings include tachycardia, hypertension, hyperthermia, dilated pupils, diaphoresis, hyperreflexia, and preserved bowel sounds. Patients may also exhibit agitation, pressured speech, paranoia, tremors, teeth grinding (bruxism), chest pain, and rhabdomyolysis. Unlike anticholinergic toxicity, patients are typically sweaty rather than dry.
Mechanism of Action
These agents stimulate the autonomic nervous system either by directly activating adrenergic receptors or indirectly by increasing catecholamine availability through enhanced release, decreased reuptake, or reduced metabolism.
Management
Treatment is largely supportive. Intravenous fluids are administered for hydration and to prevent or treat rhabdomyolysis. Benzodiazepines are first-line therapy for agitation, anxiety, and chest pain. Severe hyperthermia requires rapid cooling measures. Hypertension may be managed with benzodiazepines, vasodilators such as sodium nitroprusside, or alpha-blockers like phentolamine.
Key Points
Sources
Sympathomimetic agents are substances that stimulate the sympathetic nervous system by increasing catecholamine activity. They may act directly on receptors (e.g., alpha- or beta-agonists) or indirectly by increasing catecholamine release, blocking reuptake, or inhibiting breakdown. Common examples include cocaine, amphetamines, MDMA, ephedrine, pseudoephedrine, epinephrine, MAO inhibitors, and synthetic stimulants such as “bath salts” (e.g., mephedrone).
Typical Presentation
Patients typically present in an agitated, hyperactive state. A common scenario involves stimulant use followed by symptoms such as chest pain, anxiety, and marked vital sign abnormalities including hypertension, tachycardia, and hyperthermia.
Clinical Features
This toxidrome reflects a “fight-or-flight” response. Key findings include tachycardia, hypertension, hyperthermia, dilated pupils, diaphoresis, hyperreflexia, and preserved bowel sounds. Patients may also exhibit agitation, pressured speech, paranoia, tremors, teeth grinding (bruxism), chest pain, and rhabdomyolysis. Unlike anticholinergic toxicity, patients are typically sweaty rather than dry.
Mechanism of Action
These agents stimulate the autonomic nervous system either by directly activating adrenergic receptors or indirectly by increasing catecholamine availability through enhanced release, decreased reuptake, or reduced metabolism.
Management
Treatment is largely supportive. Intravenous fluids are administered for hydration and to prevent or treat rhabdomyolysis. Benzodiazepines are first-line therapy for agitation, anxiety, and chest pain. Severe hyperthermia requires rapid cooling measures. Hypertension may be managed with benzodiazepines, vasodilators such as sodium nitroprusside, or alpha-blockers like phentolamine.
Key Points
- Beta-blockers are generally avoided due to the risk of unopposed alpha-adrenergic vasoconstriction.
- Stimulant drugs can be easily manufactured or obtained, contributing to their widespread use.
- Sympathomimetics lower the seizure threshold, increasing the risk of seizures.
